Clinical trials
Recruiting Phase 2 Biliary Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 13 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 6 |
| Haitao Zhao, MD | 3 |
| AstraZeneca | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2 |
| AHS Cancer Control Alberta | 1 |
| Air Force Military Medical University, China | 1 |
| Asan Medical Center | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 35 |
| Cholangiocarcinoma | 6 |
| Carcinoma, Hepatocellular | 3 |
| Gallbladder Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Bile Duct Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.